Home・Akciju saraksts・Omnicell Inc

Omnicell Inc

Slēgts

SektorsVeselības aprūpe

37.27 1.72

Pirkt Pārdot

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

36.56

Max

37.44

Galvenie mērījumi
By Trading Economics
Ienākumi	13M 24M
Pārdošana	2.3M 312M
P/E Sektora vidējais	44.821 68.51
EPS	0.7
Peļņas marža	7.78
Darbinieki	3,580
EBITDA	-22M 14M

Rekomendācijas
By TipRanks
Rekomendācijas	Pirkt (spēcīgs)
Prognoze 12 mēnešiem	+49.42% upside

Dividendes
By Acuity
Nākamie ieņēmumi	2026. g. 29. okt.

Tirgus statistika
By TradingEconomics
Tirgus kapitalizācija	-175M 1.7B
Iepriekšējā atvēršanas cena	35.55
Iepriekšējā slēgšanas cena	37.27

Omnicell Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 10. aug. 19:16 UTC

News

Omnicell Inc reported second-quarter revenue of $312.21 million and upgraded its guidance, contributing to shares trading higher since Friday's close.

2026. g. 7. aug. 23:16 UTC

Omnicell Inc shares are rising in after-market trading, reflecting broader market dynamics following a disappointing jobs report that reduced interest rate hike expectations.

2026. g. 6. aug. 23:21 UTC

Omnicell Inc's shares are higher in after-market trading, showing strength following Thursday's close amid broader market dynamics and upcoming economic data.

2026. g. 5. aug. 22:02 UTC

Omnicell Inc shares are higher in after-market trading, continuing an earlier session advance. The stock remains below its 20-day moving average and one-month range.

2026. g. 4. aug. 20:07 UTC

Omnicell Inc. shares are trading lower, reflecting ongoing weakness and remaining significantly below the 20-day moving average. The stock peaked earlier in the session.

2026. g. 3. aug. 23:02 UTC

Omnicell Inc shares are lower in after-market trading, following a weak session and remaining below their 20-day moving average. No specific news was identified.

2026. g. 31. jūl. 22:01 UTC

Omnicell Inc. shares are lower in after-market trading, continuing a trend of four consecutive sessions finishing down and remaining below the 20-day moving average.

2026. g. 30. jūl. 23:21 UTC

Omnicell Inc. shares moved lower in after-market trading amid notable volatility and broader market dynamics, including mixed Asian market performance and geopolitical tensions.

2026. g. 29. jūl. 18:26 UTC

News

Omnicell Inc shares are higher as analysts maintain a positive outlook ahead of Thursday's Q2 earnings announcement, following a strong prior quarter with $309.9 million in revenue.

2026. g. 28. jūl. 20:51 UTC

Omnicell Inc shares are lower in after-market hours. The decline comes amid no specific news and follows three sessions of higher closes.

2026. g. 27. jūl. 19:46 UTC

Omnicell Inc shares are higher today, supported by falling crude oil prices and easing geopolitical tensions following U.S. diplomatic efforts with Iran.

2026. g. 24. jūl. 20:13 UTC

Omnicell Inc shares are lower in after-market hours. No specific company news was identified to explain the decline amid recent market volatility.

2026. g. 22. jūl. 18:46 UTC

News

Omnicell Inc is trading lower amid negative sentiment and concerns over financial performance. The stock's current price is $41.95.

2026. g. 21. jūl. 19:51 UTC

Omnicell Inc's shares are lower during Tuesday's session, reversing from a recent trend of higher daily closes. No specific news was identified for the decline.

2026. g. 20. jūl. 19:36 UTC

News

Omnicell Inc shares are lower amid a report suggesting the stock is one to avoid, citing modest revenue growth and declining earnings per share. Current valuation is $45.39.

Salīdzinājums

Cenas izmaiņa

Omnicell Inc Prognoze

Cenas mērķis

By TipRanks

49.42% augšup

Prognoze 12 mēnešiem

Vidējais 55 USD 49.42%

Augstākais 65 USD

Zemākais 45 USD

Pamatojoties uz 6 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Omnicell Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt (spēcīgs)

6 ratings

Pirkt

Turēt

Pārdot

Pamatojoties uz 6 analītiķiem, kas pēdējo 3 mēnešu laikā snieguši akciju vērtējumus instrumentam Omnicell Inc — pēdējo 3 mēnešu laikā.

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

Par Omnicell Inc

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots; and inventory management software. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.